Research Paper Volume 14, Issue 17 pp 7038—7051
The downregulated drug-metabolism related ALDH6A1 serves as predictor for prognosis and therapeutic immune response in gastric cancer
Figure 2. Kaplan-Meier platform showing the prognostic values of ALDH6A1, ALDH3A1 and SLC7A8 in GC. (A–I) The prognostic values of ALDH6A1, ALDH3A1 and SLC7A8 in GC patients. OS: overall survival, FP: first-progression, PPS: post progression survival.